FGH BioTech, Inc.
PrivateLast Round
Early Funding
Apr 12, 2023
Total Funding Raised
$1.18M
Company Overview
FGH BioTech, Inc. is a biopharmaceutical company that develops small-molecule drugs targeting SREBP transcription factors for the treatment of metabolic disorders and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FGH BioTech, Inc. Comparables
Compare FGH BioTech, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sagimet Biosciences | 66% | |
| Dracen Pharmaceuticals, Inc. | 63% | |
| Lime Therapeutics | 62% |
FGH BioTech, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 12, 2023 |
Key People
Founding team and executive leadership
FGH BioTech, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 12, 2023
Raised $6M in early funding.
FGH BioTech, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about FGH BioTech, Inc.'s valuation, stock price, and market status.
Is FGH BioTech, Inc. a public or private company?
FGH BioTech, Inc. is a private company.
What is the current stock price of FGH BioTech, Inc.?
FGH BioTech, Inc. is a private company with no public stock price. Caplight tracks FGH BioTech, Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is FGH BioTech, Inc. worth (valuation)?
Valuation information for FGH BioTech, Inc. is not publicly available.
Can I buy FGH BioTech, Inc. stock?
FGH BioTech, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was FGH BioTech, Inc.'s last funding round?
Funding round information for FGH BioTech, Inc. is not publicly available.
Who are the main investors in FGH BioTech, Inc.?
Investor information for FGH BioTech, Inc. is not publicly disclosed.
Will FGH BioTech, Inc. IPO soon?
No public IPO plans have been announced for FGH BioTech, Inc..
How can I track FGH BioTech, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor FGH BioTech, Inc.'s secondary market activity and sign up for updates.